Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Breathing Disorders & Treatment Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Asthma
  • 1.3.3 COPD
  • 1.3.4 Allergic rhinitis
  • 1.3.5 Pulmonary hypertension
  • 1.3.6 Cystic fibrosis
  • 1.3.7 Idiopathic pulmonary fibrosis
• 1.4 Market Segment by Application
  • 1.4.1 Global Breathing Disorders & Treatment Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Clinics
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Breathing Disorders & Treatment Market Size
  • 2.1.1 Global Breathing Disorders & Treatment Revenue 2014-2025
  • 2.1.2 Global Breathing Disorders & Treatment Sales 2014-2025
• 2.2 Breathing Disorders & Treatment Growth Rate by Regions
  • 2.2.1 Global Breathing Disorders & Treatment Sales by Regions 2014-2019
  • 2.2.2 Global Breathing Disorders & Treatment Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Breathing Disorders & Treatment Sales by Manufacturers
  • 3.1.1 Breathing Disorders & Treatment Sales by Manufacturers 2014-2019
  • 3.1.2 Breathing Disorders & Treatment Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Breathing Disorders & Treatment Revenue by Manufacturers (2014-2019)
  • 3.2.2 Breathing Disorders & Treatment Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Breathing Disorders & Treatment Market Concentration Ratio (CR5 and HHI)
• 3.3 Breathing Disorders & Treatment Price by Manufacturers
• 3.4 Key Manufacturers Breathing Disorders & Treatment Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Breathing Disorders & Treatment Market
• 3.6 Key Manufacturers Breathing Disorders & Treatment Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Asthma Sales and Revenue (2014-2019)
  • 4.1.2 COPD Sales and Revenue (2014-2019)
  • 4.1.3 Allergic rhinitis Sales and Revenue (2014-2019)
  • 4.1.4 Pulmonary hypertension Sales and Revenue (2014-2019)
  • 4.1.5 Cystic fibrosis Sales and Revenue (2014-2019)
  • 4.1.6 Idiopathic pulmonary fibrosis Sales and Revenue (2014-2019)
• 4.2 Global Breathing Disorders & Treatment Sales Market Share by Type
• 4.3 Global Breathing Disorders & Treatment Revenue Market Share by Type
• 4.4 Breathing Disorders & Treatment Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Breathing Disorders & Treatment Sales by Application

6 United States

• 6.1 United States Breathing Disorders & Treatment Breakdown Data by Company
• 6.2 United States Breathing Disorders & Treatment Breakdown Data by Type
• 6.3 United States Breathing Disorders & Treatment Breakdown Data by Application

7 European Union

• 7.1 European Union Breathing Disorders & Treatment Breakdown Data by Company
• 7.2 European Union Breathing Disorders & Treatment Breakdown Data by Type
• 7.3 European Union Breathing Disorders & Treatment Breakdown Data by Application

8 China

• 8.1 China Breathing Disorders & Treatment Breakdown Data by Company
• 8.2 China Breathing Disorders & Treatment Breakdown Data by Type
• 8.3 China Breathing Disorders & Treatment Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Breathing Disorders & Treatment Breakdown Data by Company
• 9.2 Rest of World Breathing Disorders & Treatment Breakdown Data by Type
• 9.3 Rest of World Breathing Disorders & Treatment Breakdown Data by Application
• 9.4 Rest of World Breathing Disorders & Treatment Breakdown Data by Countries
  • 9.4.1 Rest of World Breathing Disorders & Treatment Sales by Countries
  • 9.4.2 Rest of World Breathing Disorders & Treatment Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AstraZeneca
  • 10.1.1 AstraZeneca Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.1.4 Breathing Disorders & Treatment Product Introduction
  • 10.1.5 AstraZeneca Recent Development
• 10.2 Boehringer
  • 10.2.1 Boehringer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.2.4 Breathing Disorders & Treatment Product Introduction
  • 10.2.5 Boehringer Recent Development
• 10.3 GSK
  • 10.3.1 GSK Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.3.4 Breathing Disorders & Treatment Product Introduction
  • 10.3.5 GSK Recent Development
• 10.4 Merck
  • 10.4.1 Merck Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.4.4 Breathing Disorders & Treatment Product Introduction
  • 10.4.5 Merck Recent Development
• 10.5 Roche
  • 10.5.1 Roche Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.5.4 Breathing Disorders & Treatment Product Introduction
  • 10.5.5 Roche Recent Development
• 10.6 Novartis
  • 10.6.1 Novartis Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.6.4 Breathing Disorders & Treatment Product Introduction
  • 10.6.5 Novartis Recent Development
• 10.7 Abbott
  • 10.7.1 Abbott Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.7.4 Breathing Disorders & Treatment Product Introduction
  • 10.7.5 Abbott Recent Development
• 10.8 Actavis
  • 10.8.1 Actavis Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.8.4 Breathing Disorders & Treatment Product Introduction
  • 10.8.5 Actavis Recent Development
• 10.9 Afferent Pharmaceuticals
  • 10.9.1 Afferent Pharmaceuticals Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.9.4 Breathing Disorders & Treatment Product Introduction
  • 10.9.5 Afferent Pharmaceuticals Recent Development
• 10.10 Alere
  • 10.10.1 Alere Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Breathing Disorders & Treatment
  • 10.10.4 Breathing Disorders & Treatment Product Introduction
  • 10.10.5 Alere Recent Development
• 10.11 Almirall
• 10.12 Amgen
• 10.13 AptarGroup
• 10.14 Astellas
• 10.15 Aurobindo
• 10.16 Axis-Shield
• 10.17 Baxter
• 10.18 Bayer
• 10.19 Biogen
• 10.20 Biotest
• 10.21 Bristol-Myers Squibb
• 10.22 Chiesi Farmaceutici
• 10.23 Cipla
• 10.24 Cytos
• 10.25 Dainippon Sumitomo
• 10.26 Dr. Reddy's Laboratories

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Breathing Disorders & Treatment Sales Channels
  • 11.2.2 Breathing Disorders & Treatment Distributors
• 11.3 Breathing Disorders & Treatment Customers

12 Market Forecast

• 12.1 Global Breathing Disorders & Treatment Sales and Revenue Forecast 2019-2025
• 12.2 Global Breathing Disorders & Treatment Sales Forecast by Type
• 12.3 Global Breathing Disorders & Treatment Sales Forecast by Application
• 12.4 Breathing Disorders & Treatment Forecast by Regions
  • 12.4.1 Global Breathing Disorders & Treatment Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Breathing Disorders & Treatment Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF). The causes of respiratory disorders vary significantly across each indication, and include factors such as environment, occupation, genetic predisposition and aging.
In 2019, the market size of Breathing Disorders & Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Breathing Disorders & Treatment.

This report studies the global market size of Breathing Disorders & Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Breathing Disorders & Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Boehringer
GSK
Merck
Roche
Novartis
Abbott
Actavis
Afferent Pharmaceuticals
Alere
Almirall
Amgen
AptarGroup
Astellas
Aurobindo
Axis-Shield
Baxter
Bayer
Biogen
Biotest
Bristol-Myers Squibb
Chiesi Farmaceutici
Cipla
Cytos
Dainippon Sumitomo
Dr. Reddy's Laboratories

Market Segment by Product Type
Asthma
COPD
Allergic rhinitis
Pulmonary hypertension
Cystic fibrosis
Idiopathic pulmonary fibrosis

Market Segment by Application
Hospital
Clinics
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Breathing Disorders & Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Breathing Disorders & Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Breathing Disorders & Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025